Travellers heading to China have been urged to exercise caution following a spike in Chikungunya virus cases, with over 7,000 infections reported across the country. The outbreak has prompted China to adopt drastic containment efforts reminiscent of its previous COVID-19 measures, including quarantining patients until they test negative and deploying biological agents like fish and genetically modified mosquitoes to combat virus-carrying insects.
Thousands Infected in Guangdong, First Case Detected in Hong Kong
The majority of cases have emerged from Guangdong province, affecting at least 12 cities. Foshan is currently among the hardest-hit areas. Worryingly, the virus has also crossed borders, with Hong Kong confirming its first case—a 12-year-old boy who recently travelled to Foshan and fell ill shortly after.
In just one week, China documented 3,000 new Chikungunya infections, prompting swift intervention from health authorities. Measures include covering patients with mosquito nets, eliminating stagnant water to reduce breeding grounds, and even releasing “elephant mosquitoes” and fish to help suppress the spread.
These efforts mirror the country’s aggressive pandemic-era tactics, highlighting the seriousness of the situation.
What Is the Chikungunya Virus?
Chikungunya is a mosquito-borne viral disease primarily transmitted by Aedes mosquitoes—the same type responsible for dengue and Zika outbreaks. The virus was first identified in Tanzania in 1952 and has since spread to over 110 countries worldwide.
Symptoms typically include high fever, joint pain, muscle aches, rashes, and swelling. While most individuals recover within 7 to 10 days, joint pain can persist for years in severe cases. Though rarely fatal, the virus poses significant risks to the elderly, infants, pregnant women, and individuals with chronic illnesses such as diabetes or heart disease.
The World Health Organisation (WHO) warns that 5.6 billion people globally live in areas at risk of exposure.
US Issues Level 2 Travel Advisory
In response to the outbreak, the US Centres for Disease Control and Prevention (CDC) has issued a Level 2 travel alert for China, advising visitors to “practise enhanced precautions.” This advisory means travellers should take steps such as using insect repellent, wearing long clothing, and staying in air-conditioned or screened accommodations.
The CDC also recommends considering vaccination—two approved Chikungunya vaccines are currently available in the US. Particularly vulnerable travellers, including pregnant women near delivery, are strongly advised to avoid affected areas altogether, as the virus can be transmitted to newborns during childbirth, potentially leading to serious complications.
Other countries facing similar Level 2 advisories include Bolivia, Sri Lanka, Mauritius, Madagascar, and parts of Africa and the Indian Ocean region. Elevated risk alerts have also been issued for countries like Brazil, India, the Philippines, and Thailand.
Experts Warn of Global Pattern Resembling 2004 Outbreak
Health experts have cautioned that the current outbreak in China reflects a worrying trend. Professor Yuen Kwok-yung from the University of Hong Kong noted that since humans have no natural immunity to the virus, the outbreak could easily escalate.
WHO’s Dr Rojas Alvarez added that the current spread mirrors patterns seen during the 2004–2005 Indian Ocean outbreak, which affected a large percentage of populations in affected areas such as Réunion and Mauritius. She stressed the urgent need for preventive measures to avoid repeating history.
With travel season in full swing and mosquito populations thriving in warmer weather, travellers are urged to remain vigilant, not only in China but in any country reporting Chikungunya activity.
Image Source: Singapore Uncensored